Literature DB >> 21964674

Combined modality therapy for laryngeal cancer with superselective intra-arterial cisplatin infusion and concomitant radiotherapy.

Shigenari Taki1, Akihiro Homma, Fumiyuki Suzuki, Nobuhiko Oridate, Hiromitsu Hatakeyama, Takatsugu Mizumachi, Satoshi Kano, Jun Furusawa, Tomohiro Sakashita, Naoya Inamura, Daisuke Yoshida, Rikiya Onimaru, Hiroki Shirato, Satoshi Fukuda.   

Abstract

Concomitant radiotherapy and superselective arterial infusion of cisplatin for laryngeal cancer has shown excellent therapeutic outcomes. It is expected to be a reasonable treatment option for laryngeal cancer, especially in locally advanced cases.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21964674     DOI： 10.1007/s10147-011-0308-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


  18 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report.

Authors:  C T KLOPP; T C ALFORD; J BATEMAN; G N BERRY; T WINSHIP
Journal:  Ann Surg       Date:  1950-10       Impact factor: 12.969

3.  Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy.

Authors:  H A Freckman
Journal:  Am J Surg       Date:  1972-10       Impact factor: 2.565

4.  Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients.

Authors:  K T Robbins; P Kumar; F S Wong; W F Hartsell; P Flick; R Palmer; A B Weir; H B Neill; T Murry; R Ferguson; C Hanchett; F Vieira; A Bush; S B Howell
Journal:  Head Neck       Date:  2000-10       Impact factor: 3.147

5.  A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer.

Authors:  K T Robbins; D Vicario; S Seagren; R Weisman; P Pellitteri; C Kerber; L Orloff; G Los; S B Howell
Journal:  Am J Surg       Date:  1994-11       Impact factor: 2.565

6.  Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.

Authors:  Akihiro Homma; Nobuhiko Oridate; Fumiyuki Suzuki; Shigenari Taki; Takeshi Asano; Daisuke Yoshida; Rikiya Onimaru; Takeshi Nishioka; Hiroki Shirato; Satoshi Fukuda
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

7.  Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck.

Authors:  Anna Rabbani; Russell W Hinerman; Ilona M Schmalfuss; Robert J Amdur; Christopher G Morris; Keith R Peters; K Thomas Robbins; William M Mendenhall
Journal:  Am J Clin Oncol       Date:  2007-06       Impact factor: 2.339

Review 8.  Recent changes in the treatment of patients with advanced laryngeal cancer.

Authors:  Eric M Genden; Alfio Ferlito; Alessandra Rinaldo; Carl E Silver; Johannes J Fagan; Carlos Suárez; Johannes A Langendijk; Jean Louis Lefebvre; Patrick J Bradley; C René Leemans; Amy Y Chen; Jemy Jose; Gregory T Wolf
Journal:  Head Neck       Date:  2008-01       Impact factor: 3.147

9.  Feeding artery of laryngeal and hypopharyngeal cancers: role of the superior thyroid artery in superselective intraarterial chemotherapy.

Authors:  Noboru Terayama; Junichiro Sanada; Osamu Matsui; Satoshi Kobayashi; Hiroko Kawashima; Masashi Yamashiro; Tsuyoshi Takanaka; Tomoyasu Kumano; Tomokazu Yoshizaki; Mitsuru Furukawa
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Jul-Aug       Impact factor: 2.740

10.  Selective (intra-arterial), rapid infusion chemo-radiotherapy to preserve the larynx in advanced laryngeal carcinoma: preliminary results.

Authors:  T Nakashima; T Mihoki; T Ono; H Umeno; N Tanaka
Journal:  J Laryngol Otol Suppl       Date:  2009
View more
  1 in total

1.  Photothermolysis mediated by gold nanorods modified with EGFR monoclonal antibody induces Hep-2 cells apoptosis in vitro and in vivo.

Authors:  Shiwen Zhang; Yunlong Li; Xiaoguang He; Shouan Dong; Yunchao Huang; Xiaojiang Li; Yuxiao Li; Congguo Jin; Yingying Zhang; Yuanling Wang
Journal:  Int J Nanomedicine       Date:  2014-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.